Genmab launches ChatGPT Enterprise — enhanced security and privacy

AI Impact Summary

Genmab’s adoption of ChatGPT Enterprise represents a strategic shift towards integrating generative AI across their operations. Leveraging OpenAI’s Enterprise offering, specifically designed for enhanced security and privacy, suggests a commitment to responsible AI implementation within a regulated industry. This move likely aims to improve internal workflows, accelerate research, and potentially enhance patient engagement through AI-powered tools.